Spaces:
Sleeping
Sleeping
| country,market,cluster,region | |
| US,Growth Hormone Market,Endo NA,NA | |
| CA,Growth Hormone Market,Endo NA,NA | |
| US,FSH/hMG Market,FE NA,NA | |
| CA,FSH/hMG Market,FE NA,NA | |
| "AT, BE, CH, CZ, DE, DK, ES, FI, FR, GB, GR, HU, IT, NL, NO, PL, PT, SE",FSH/hMG Market,EUROPE,EU | |
| "DE, FR, IT, ES, GB",FSH/hMG Market,EU5,EU | |
| "AT, CZ, DK, FI, GR, HU, NL, NO, PL, PT, SE, BE, CH",FSH/hMG Market,Mid-EU,EU | |
| "AT, BE, CH, CZ, DE, DK, ES, FI, FR, GB, GR, HU, IT, NL, NO, PL, PT, SE",MS High Efficacy Market,EUROPE,EU | |
| "DE, FR, IT, ES, GB",MS High Efficacy Market,EU5,EU | |
| "AT, CZ, DK, FI, GR, HU, NL, NO, PL, PT, SE, BE, CH",MS High Efficacy Market,Mid-EU,EU | |
| "AT, BE, CH, CZ, DE, DK, ES, FI, FR, GB, GR, HU, IT, NL, NO, PL, PT, SE",Beta Blocker Market,EUROPE,EU | |
| "DE, FR, IT, ES, GB",Beta Blocker Market,EU5,EU | |
| "AT, CZ, DK, FI, GR, HU, NL, NO, PL, PT, SE, BE, CH",Beta Blocker Market,Mid-EU,EU | |
| "AT, BE, CH, CZ, DE, DK, ES, FI, FR, GB, GR, HU, IT, NL, NO, PL, PT, SE",Antihypertensive Combo Market,EUROPE,EU | |
| "DE, FR, IT, ES, GB",Antihypertensive Combo Market,EU5,EU | |
| "AT, CZ, DK, FI, GR, HU, NL, NO, PL, PT, SE, BE, CH",Antihypertensive Combo Market,Mid-EU,EU | |
| "AT, BE, CH, CZ, DE, DK, ES, FI, FR, GB, GR, HU, IT, NL, NO, PL, PT, SE",Hypothyroid Market,EUROPE,EU | |
| "DE, FR, IT, ES, GB",Hypothyroid Market,EU5,EU | |
| "AT, CZ, DK, FI, GR, HU, NL, NO, PL, PT, SE, BE, CH",Hypothyroid Market,Mid-EU,EU | |
| "AT, BE, CH, CZ, DE, DK, ES, FI, FR, GB, GR, HU, IT, NL, NO, PL, PT, SE",Growth Hormone Market,EUROPE,EU | |
| "DE, FR, IT, ES, GB",Growth Hormone Market,EU5,EU | |
| "AT, CZ, DK, FI, GR, HU, NL, NO, PL, PT, SE, BE, CH",Growth Hormone Market,Mid-EU,EU | |
| "AT, BE, CH, CZ, DE, DK, ES, FI, FR, GB, GR, HU, IT, NL, NO, PL, PT, SE",Anti-EGFR Market,EUROPE,EU | |
| "DE, FR, IT, ES, GB",Anti-EGFR Market,EU5,EU | |
| "AT, CZ, DK, FI, GR, HU, NL, NO, PL, PT, SE, BE, CH",Anti-EGFR Market,Mid-EU,EU | |
| "CZ, FI, FR, DE, HU, IT, NO, PT, SE, CH, GB",Growth Hormone Market,Endo Europe,EU | |
| "BE, CZ, FI, FR, DE, GR, HU, IT, NO, PL, PT, ES, CH, NL",Injectable Platform Market,NIM Europe,EU | |
| "BE, CZ, FI, FR, DE, GR, HU, IT, NO, PL, PT, ES, CH, NL",MS High Efficacy Market,NIM Europe,EU | |
| "BE, CZ, FI, FR, DE, GR, HU, IT, NO, PL, PT, ES, CH, AT",Beta Blocker Market,CV Europe,EU | |
| "AT, BE, CZ, FI, FR, DE, GR, HU, IT, NO, PL, PT, ES, CH, DK, NL",Hypothyroid Market,THY Europe,EU | |
| "AT, BE, CZ, FI, FR, DE, GR, HU, IT, NO, PL, PT, ES, CH, DK, NL",Hyperthyroid Market,THY Europe,EU | |
| "MX, AR",Growth Hormone Market,Endo LATAM,LATAM | |
| "BR, CL, MX, PE, CO",Injectable Platform Market,NIM LATAM,LATAM | |
| "BR, CL, MX, PE, CO",MS High Efficacy Market,NIM LATAM,LATAM | |
| "BR, CL, MX, PE, CO",Beta Blocker Market,CV LATAM,LATAM | |
| "BR, CL, MX, PE, CO",Hypothyroid Market,THY LATAM,LATAM | |
| "AU, HK, IN, ID, KR, MY, PH, SG, TW, TH, VN",FSH/hMG Market,APAC Total,APAC | |
| "AU, HK, ID, KR, MY, PH, SG, TW, TH, VN",Growth Hormone Market,APAC Total wo IN,APAC | |
| "AU, HK, ID, MY, SG, KR, TW, TH",Injectable Platform Market,APAC MS Cluster,APAC | |
| "AU, HK, ID, MY, SG, KR, TW, TH",MS High Efficacy Market,APAC HE MS Cluster,APAC | |
| "HK, IN, ID, MY, PH, SG, TH, VN",Beta Blocker Market,APAC Direct Cluster,APAC | |
| "HK, ID, MY, PH, SG, TH, VN",Antihypertensive Combo Market,APAC Direct Cluster wo IN,APAC | |
| "HK, ID, MY, PH, SG, TH, VN",Hypothyroid Market,APAC Direct Cluster wo IN,APAC | |
| "ID, VN",Hyperthyroid Market,APAC Hyperthyroid Cluster,APAC | |
| "HK, KR, SG, TW",MET Inhibitor Market,APAC METi Cluster wo IN,APAC | |
| "AU, HK, IN, MY, PH, SG, TW, TH",Anti-EGFR Market,APAC Anti-EGFR Cluster,APAC | |
| "AU, TW, HK, ID, PH, KR, TH, VN, MY",Growth Hormone Market,Endo APAC,APAC | |
| "AU, TW, HK, ID, PH, KR, TH, VN, MY",Hypothyroid Market,THY APAC,APAC | |
| "HK, ID, TH, PH, VN",MS High Efficacy Market,NIM APAC,APAC | |
| "HK, ID, TH, PH, VN",Injectable Platform Market,NIM APAC,APAC | |
| "AU, TW, HK, ID, PH, KR, TH, VN, MY",Hyperthyroid Market,THY APAC,APAC | |
| "HK, IN, ID, PH, TH, VN",Beta Blocker Market,CV APAC,APAC | |
| "SA, EG, AE",Growth Hormone Market,Endo MEAR,MEAR | |
| "MA, ZA, AE, EG, SA",MS High Efficacy Market,NIM MEAR,MEAR | |
| "MA, ZA, AE, EG, SA",Injectable Platform Market,NIM MEAR,MEAR | |
| "MA, ZA, AE, EG, SA",Beta Blocker Market,CV MEAR,MEAR | |
| "US, CA, CZ, FI, FR, DE, HU, IT, NO, PT, SE, CH, GB, AU, TW, HK, ID, PH, KR, TH, VN, MY, SA, EG, AE, MX, AR",Growth Hormone Market,Endo Global,Global | |